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ABSTRACT: Human pluripotent stem cell (hPSC)-derived
endothelial cells (ECs) are promising cell sources for drug
discovery, tissue engineering, and studying or treating vascular
diseases. However, hPSC-ECs derived from different culture
methods display different phenotypes. Herein, we made a detailed
comparative study of hPSC-ECs from three different culture
systems (e.g., 2D, 3D PNIPAAm-PEG hydrogel, and 3D alginate
hydrogel cultures) based on our previous reports. We expanded
hPSCs and differentiated them into ECs in three culture systems.
Both 3D hydrogel systems could mimic an in vivo physiologically
relevant microenvironment to protect cells from shear force and
prevent cell agglomeration, leading to a high culture efficiency and
a high volumetric yield. We demonstrated that hPSC-ECs
produced from both hydrogel systems had similar results as 2D-ECs. The transcriptome analysis showed that PEG-ECs and
alginate-ECs displayed a functional phenotype due to their higher gene expressions in vasculature development, extracellular matrix,
angiogenesis, and glycolysis, while 2D-ECs showed a proliferative phenotype due to their higher gene expressions in cell
proliferation. Taken together, both PEG- and alginate-hydrogel systems will significantly advance the applications of hPSC-ECs in
various biomedical fields.
■ INTRODUCTION
Endothelial cells (ECs), which play an important role in
normal vascular functions and a variety of vascular diseases,1,2
are promising cell sources for drug screening, cell therapy, and
tissue engineering.3−11 However, because of the limited
proliferation capability and quick phenotype change during
in vitro culturing, obtaining enough primary ECs for basic
applications remains very challenging.12−17 Human pluripotent
stem cells (hPSCs), including human embryonic stem cells
(hESCs)18 and induced pluripotent stem cells (iPSCs),19,20
provide a potential solution to this challenge21 due to their
unlimited proliferation capability and the ability to differentiate
into all somatic cell types of the human body.22,23 In particular,
patient-derived iPSCs contain the patient’s genetic information
and could model many human diseases. Currently, the
methods of hPSC differentiation into ECs in a 3D
suspension21,24−29 or 2D monolayer4,30−33 have been estab-
lished.
Although efficient differentiation protocols of hPSC-ECs
have been developed,33−37 bioprocesses applying these
methods to produce enough hPSC-ECs and functional ECs
are still lacking. Current 2D cell culturing (e.g., cell culture
well-plate), which has a low cell yield and often displays a
proliferative phenotype,38,39 is only suitable for preparing small
numbers of cells.40,41 3D suspension culturing (e.g., bio-
reactors) has been widely used to prepare large numbers of
cells. However, these studies also revealed significant
challenges,23,40−45 such as large cell agglomerates due to
frequent cell-to-cell interactions (e.g., hPSCs)40 and insuffi-
cient mass transport leading to low cell production, cell death,
and spontaneous differentiation.40 Cell culture through
agitation could reduce cell agglomeration, but it also generates
a shear force leading to significant cell death.40,46,47
To address the challenges mentioned above, we previously
reported two scalable and high-cell-yield methods for
expanding hPSCs.23,48 With those two methods, hPSCs are
cultured in a 3D PNIPAAm-PEG (3D-PEG) hydrogel and
microscale alginate (3D-alginate) hydrogel tubes, followed by
EC differentiation. Both hydrogels could protect cells from the
shear force in the culture environment and ensure efficient
mass transport during the culturing period. Furthermore, the
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two hydrogels provide a highly uniform and physiologically
relevant microenvironment for hPSC growth. Then, we
systemically explored the comparative study of hPSC-ECs
from three different culture systems through the following
aspects: cell production, cell differentiation, gene expression,
and functional properties. We found ECs derived from hPSCs
could be produced with high culture efficiency in both
hydrogel culture systems. The whole transcriptome analysis
showed 3D-PEG-ECs and 3D-alginate-ECs had higher gene
expressions in vasculature development, extracellular matrix,
and glycolysis, indicating their functional phenotype, while 2D-
ECs had higher gene expressions in cell proliferation,
indicating their proliferative phenotype. We also demonstrated
that hPSC-ECs made in three culture systems had similar
results as hPSC-ECs generated in 2D culture methods. Taken
together, both 3D-PEG- and 3D-alginate-hydrogel systems
with high culture efficiency will significantly advance the
applications of hPSC-derived ECs in various biomedical fields.
■ RESULTS
hPSC Expansion in 2D, 3D-PEG, and 3D-Alginate
Culture Systems. The starting cells H9 hESCs were checked
and confirmed to be high-quality pluripotent stem cells
according to our previous studies.49 The detailed method for
processing and culturing hPSCs in the 3D-PNIPAAm-PEG
hydrogel23 and microscale alginate hydrogel tubes48 has been
reported in our previous publications (Figure 1). The storage
modulus (G′) (∼800 Pa) and the optimal concentration
(10%) of PNlPAAm-PEG (∼800 Pa) for hPSC biology and
culture were identified in previous studies,23 and the optimal
concentration (1.5%) of the sodium alginate hydrogel was
determined in our previous studies.48 Single hPSCs first form
small clusters or small colonies after 24 h when cultured in the
three systems, followed by forming a cell sheet or mass in
about 3, 5, and 9 days, respectively (Figure 2A). Immunostain-
ing showed that the majority of the cells culturing in the three
systems expressed pluripotent stem cell markers including
OCT3/4 and NANOG (Figure 2B−D). Live-/dead-cell
staining revealed that very few dead cells were observed
during the culturing (Figure 2E,F). When we seeded at 1.0 ×
106 cells/mL, hPSCs expanded with about 7-fold expansion to
yield ∼7 × 106 cells/mL on day 3 in the 2D culture system,
about 20-fold expansion, yielding ∼20 million cells/mL, on day
5 in the 3D-PEG hydrogel system, and ∼480-fold to yield
∼480 × 106 cells/mL on day 9 in the 3D-alginate hydrogel
system(Figure 2G,H). H9s and iPSCs had similar outcomes
according to our previous studies.50,51 The results confirm that
expanding hPSCs in both hydrogels is robust and reproducible.
Differentiating hPSCs into ECs in Three Systems. An
efficient, simple, and quick method reported by Patsch et al.,
which could generate ECs from hPSCs in 6 days in 2D
culturing,4 is a great promising method for producing ECs for
biomedical applications (Figure 3A). The produced ECs had
the cobblestone morphology typical for ECs, according to the
protocol mentioned above (Figure 3B). A majority of the
hPSC-derived ECs expressed EC markers including PECAM1
and VE-cadherin, as indicated by immunostaining (Figure 3C).
Flow cytometry analysis found >80% of the cells were CD31+/
CD144+ (Figure 3D,E). According to our previous stud-
ies,50,51 we demonstrated ∼13.8% or ∼11% ± 1.8% was
positive for smooth muscle cells markers, SM22A and
CD140b, and no OCT4+ and NANOG+ undifferentiated
hPSCs were detected. Expansions of about 16-fold, 1.6 × 107
cells/mL, in the 2D system, about 20-fold, 2 × 107 cells/mL, in
the 3D-PEG hydrogel system, and about 450-fold, 4.5 × 108
cells/mL, in the 3D-alginate hydrogel system were produced
on day 10(Figure 3G,H). H9s and iPSCs had similar
outcomes, according to our previous studies.50,51 Our results
indicated the robustness of the differentiation protocol
reported by Patsch et al.4
Properties of All ECs Made in Three Systems. Both
hydrogel systems provide a physiologically relevant micro-
environment for cell growth. Previous reports demonstrated
that ECs cultured in a 3D microenvironment displayed
different phenotypes and functional properties compared to
those cultured in 2D substrates.38,39 We thus asked if 3D-PEG-
ECs, 3D-alginate-ECs, and traditional 2D-ECs displayed
similar phenotypes, functions, and gene expressions. We
found that they had a similar capability of lipid uptake via
fluorescently labeled acetylated LDL (Ac-LDL) and micro-
scope imaging (Figure 4A), and they formed similar tubular
structures, indicating their similar angiogenic potential through
the tube formation assay (Figure 4B−D). 3D-PEG-ECs, 3D-
alginate-ECs, and traditional 2D-ECs had tight barriers, as
indicated by the high trans-endothelial electrical resistance
(TEER) value assay.52 With the administration of TNF-α, IL-
Figure 1. Overview of three culture systems for hPSC expansion and
differentiation. (A) Schematic illustration of 2D culture expansion and
differentiation of hPSCs. (B) Schematic illustration of the bioprocess
of the 3D PNIPAAm-PEG hydrogel for hPSC expansion and
differentiation. Single hPSCs (1.0 × 106 cells/mL PEG hydrogel)
are mixed with a 10% PNIPAAm-PEG solution at a low temperature
[e.g., 4 °(C)], which forms an elastic hydrogel at 37 °C. Single hPSCs
clonally expand into uniform spheroids in the hydrogel in 5 days.
Upon cooling to 4 °C, the hydrogel is liquefied, and spheroids are
harvested and dissociated into single cells for the next expansion.
Once the targeted cell number is reached, hPSCs are differentiated
into ECs in the hydrogel. (C) Schematic illustration of the 3D
alginate hydrogel for hPSC expansion and differentiation. hPSCs are
processed into alginate hydrogel tubes at a low seeding density (1.0 ×
106 cells/mL alginate hydrogel) and expanded for 9 days to fill the
tubes. The day 9 cell masses can be released via dissolving the
hydrogel tubes with 0.5 mM EDTA solution, dissociated into single
cells with Accutase, and processed into new hydrogel tubes for a
second round of expansion. Once the targeted cell number of hPSCs
is reached, hPSCs (around day 5) can be differentiated into ECs in
the alginate hydrogel.
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1β, and VEGF-A, the barrier tightness of all ECs was disrupted
by a sharp decrease of the TEER values and displayed similar
results as the primary human umbilical vein endothelial cells
(HUVECs) (Figure 4E). To investigate the angiogenic
potential of 3D-PEG-ECs, 3D-alginate-ECs, and 2D-ECs in
vivo, we injected ECs from different systems with a Matrigel
matrix into the immunodeficient mice. The results revealed the
formation of a blood vessel structure in the matrix for all ECs,
as indicated by hematoxylin and eosin (H&E)-staining and
immunostaining, and both hydrogel system-derived ECs
displayed a significant increase of mean fluorescence intensity,
based on CD31 fluorescent signals (Figure 4F,G). We also
used qRT-PCR to quantitatively measure the gene expressions
related to ECs, including the surface markers (CD31, CD144,
vWF, and CD34), growth factors (VEGFA and VEGFC), and
extracellular matrices (FN and COL4A6). Both 3D-PEG-ECs
and 3D-alginate-ECs had increased expressions of the EC
genes compared with that of 2D-ECs or HUVECs, while
alginate-ECs displayed higher gene expressions of CD31,
CD144, vWF, VEGFA, and VEGFC (Figure 4H,I). H9s and
iPSCs had similar outcomes, according to our previous
studies.50,51
Transcriptome Analysis of All ECs Generated from
Three Systems. Next, we performed the whole transcriptome
analysis by sequencing the mRNAs of the undifferentiated H9s,
2D-ECs, 3D-PEG-ECs, and 3D-alginate-ECs (three biological
replicates for each group) to assess differential expression
genes (DEGs). Hierarchical clustering analysis showed all
hPSC-ECs from three systems clustered closely and displayed
very different gene expressions from that of H9s (Figure 5A).
Principal component analysis (PCA) showed slightly different
gene expressions among all ECs, but very different from that of
H9s (Figure 5B). The correlation coefficients between 3D-
alginate-ECs/2D-ECs, 3D-PEG-ECs/2D-ECs, and 3D-PEG-
ECs/3D-alginate-ECs were >0.78, >0.83, and >0.82, respec-
tively, indicating similar global gene expressions (Figure
5C,D). The top 10 upregulated GO term analysis showed
that genes of both 3D-PEG-ECs and 3D-alginate-ECs are
enriched in the cardiovascular system development, vasculature
development, blood circulation, angiogenesis, and ECM
assembly (Figure 6A,B), and genes of 2D-ECs are enriched
in the cell cycle and proliferation and oxidative stress response.
A Venn diagram showed that the number of DEGs in both 3D-
hydrogel systems was significantly higher than that of the
traditional 2D culture system. These results indicated that a 3D
Figure 2. Comparison of hPSC expansion in three culture systems. (A) Phase image of hPSC expansion in 2D, 3D-PEG, and 3D-alginate culture
systems. Scale bar, 50 μm. (B) Immunostaining of the pluripotency markers OCT3/4 and NANOG in 2D, 3D-PEG, and 3D-alginate culture
systems. Scale bars, 50 μm. (C,D) Statistical analysis of OCT3/4- and NANOG-positive cells in 2D, 3D-PEG, and 3D-alginate culture systems.
(E,F) Live-/dead-cell staining and statistical analysis of harvested cells from 2D, 3D-PEG, and 3D-alginate culture systems. Scale bar, 200 μm.
(G,H) When seeded at 1.0 × 106 cells/mL, about 7-fold expansion occurs to yield ∼7 × 106 cells/mL on day 3 in the 2D culture system; about 5-,
10-, and 20-fold expansion, yielding ∼5, 10, and 20 million cells per milliliter of the hydrogel on days 3, 4, and 5, respectively, is achieved in the 3D-
PEG culture system; and about ∼30-, 150-, and 480-fold expansion occur to yield ∼30×, 150×, and 480 × 106 cells/mL on days 5, 7, and 9,
respectively, in the 3D-alginate culture system. Data are represented as mean ± SD (n = 3).
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environment promoted functional EC formation, while 2D
culturing induced ECs to have a proliferative phenotype. Our
results were consistent with the literature.38,39
Detailed gene expression analysis with the RNA-Seq data
showed the following differences among 3D-PEG-ECs, 3D-
alginate-ECs, and 2D-ECs: (a) both hydrogel systems had
similar expressions of ECM genes, including collagens:
COL23A1, COL20A1, COL3A1, COL11A2, COL6A6,
COL6A3, COL14A1, COL24A1, COL4A4, COL16A1,
COL25A1, COL27A1, COL5A1, and COL6A5, but different
Figure 3. Comparison of hPSC-derived ECs in three culture systems. (A) Schematic illustration of the EC differentiation protocol. (B) Phase
images of hPSC-ECs on day 5 in 2D, 3D-PEG, and 3D-alginate culture systems. Scale bar, 200 μm. (C) Immunostaining analysis of EC markers
PECAM1 (or CD31) and VE-cadherin (or CD144) on day 5 cells. Scale bar, 50 μm. (D,E) Flow cytometry analysis of EC markers CD31 and
CD144 on day 5 cells. (F,G) When seeded at 1.0 × 106 cells/mL, about 16-, 25-, and 400-fold expansion, yielding ∼1.6 × 107 ECs/mL, 2.0 × 107
ECs/mL PEG hydrogel, and ∼4.0 × 108 ECs/mL alginate hydrogel, are produced in 2D, 3D-PEG, and 3D-alginate culture systems on day 5,
respectively.
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expressions in COL21A1; laminins: LAMC3, but different
expressions in LAMB3, LAMB4, LAMC2, and LAMA4; other
ECM components: DCN, THBS2, HSPG2, FN1, THSD1, and
VWF; proteases: MMP9, MMP23B, MMP24, and MMP16,
but different expressions in MMP17 and MMP3; and integrins:
ITGA2, ITGB2, ITGB3, ITGA2B, ITGA6, ITGA10, ITGB8,
and ITGA9, but different expressions in ITGA11 (Figure 6C−
G); 2D-ECs had higher expressions of ECM genes, including
collagens: COL11A1, COL8A2, COL2A1, and COL12A1;
laminins: LAMC1; other ECM components: EFEMP1, NTN1,
and FBN1; proteases: MMP11, MMP1, TIMP3, TIMP2,
MMP15, MMP2, and MMP19; and integrins: ITGAL, ITGB6,
ITGA7, ITGB4, ITGB5, ITGAV, ITGAX, and ITGB7 (Figure
6C−G). (b) Both hydrogel systems had higher expressions of
genes for EC-secreted factors, including MMP9, IGF1,
TNFRSF10C, VEGFA, CCL5, IGFBP1, IGFBP2, CXCL16,
ANGPT1, FGF10, ANGPT2, IL1B, VEGFB, CDH5, VEGFC,
and PECAM1, but different expressions in IL6, ANG,
CXCL10, TGFA, CXCL11, IL8, FGF2, IL7, HBEGF,
PDGFA, and EGF (Figure 6H); 2D-ECs had higher
expressions of genes for EC-secreted factors, including
CXCL1, CCL7, CTGF, CXCL2, CXCL6, HGF, CCL2,
TIMP2, CXCL5, and FGF1 (Figure 6H). (c) Both hydrogel
systems had higher expressions of genes for glycolysis,
including ENO2, GPI, PGK2, PGK1, PGAM2, PGM2,
ALDOB, and PFKL (Figure 6I), and angiogenesis (Figure
6J). (d) 2D-ECs had higher gene expressions in the cell cycle
and proliferation (Figure 6K).
■ DISCUSSION
hPSC-derived ECs are produced either in a traditional 2D
culture or in a 3D suspension culture. However, because the
Figure 4. Functional properties of ECs derived from three culture systems. (A) Uptake by fluorescence-labeled acetylated LDL (Ac-LDL). Scale
bar, 50 μm. (B−D) All ECs form a tubular network when plated on Matrigel for 24 h. The tube length (mm/field) (C) and branches (D) are
calculated using the Angiogenesis Analyzer of ImageJ software. Scale bar, 50 μm. *p < 0.05, **p < 0.01. (E) TEER properties of HUVECs, 3D-
alginate-ECs, 3D-PEG-ECs, and 2D-ECs (either untreated or treated with 100 ng/mL TNF-α or 100 ng/mL IL-1β or 100 ng/mL VEGF-A) are
similar. ***p < 0.001. (F,G) When transplanted subcutaneously with a Matrigel matrix, all ECs form vascular structures, as indicated by H&E
staining and immunostaining analysis. Scale bar, 100 and 25 μm. (H,I) qRT-PCR shows that 3D-PEG-ECs and 3D-alginate-ECs have higher
expressions of the key genes related to ECs compared with 2D-ECs or HUVECs. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
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culturing conditions are very different from the physiologically
relevant microenvironments, both cultures have difficulty in
generating large numbers of high-quality ECs for drug
discovery, tissue engineering, and cell therapies.18,53−56 For
2D culturing, it is only considered suitable for preparing small-
scale cells due to its labor-, space-, and reagent-consumption
requirements.40 For 3D suspension culturing, it results in large
cell agglomerates due to frequent cell-to-cell interactions (e.g.,
hPSCs)40 and the insufficient mass transport to cells located at
the center of the large agglomerates (e.g., > 400 μm diameter),
leading to low cell production, cell death, and spontaneous
differentiation.40 In summary, the large cell aggregation and
the critical shear force make it difficult to culture hPSCs and
their derivatives in large scales in 3D suspension culturing.
Although moving the 2D cell culture to 3D cell culture (e.g.,
fibrin or Matrigel) is an attractive approach for scaling up
production,44,57 they also highlight significant challenges for
the 3D hPSC culture. Animal-derived Matrigel has some
challenges, including the variation between the production
batches, undefined composition, and lack of controlled
physical properties, and it also influences the gene expression
of cells. In addition, both Matrigel and fibrin are not easy to
manipulate for the cell culture and have limited reproducibility
and scalability and the risks for pathogen and immunogen
transfer; thus, they are not considered as good manufacturing
practice cell production.
Based on our previous studies, we have managed to expand
and differentiate hPSCs in 3D-PEG hydrogel51 and 3D-
alginate hydrogel cultures.50 In this article, we made a detailed
comparative study for hPSC-ECs derived from the traditional
2D culture, 3D-PEG hydrogel culture, and 3D-alginate
hydrogel culture. We found that both hydrogel systems had
similar results as hPSC-derived ECs in conventional cell
culture methods and had similar whole transcriptional gene
expression patterns. However, the high culture efficiency
makes the 3D-alginate hydrogel culture system very attractive
for large-scale and high-quality cell production. The 3D-
alginate hydrogel culture system eliminates both the cell
agglomeration and shear force and their related side effects.
hPSC-derived ECs could be produced in the alginate hydrogel
system with a high culture efficiency and high yield (∼5.0 ×
108 cells/mL). About 250 times of the yield in 3D suspension
culturing and ∼25 times of the yield in the 3D-PEG hydrogel
culture system was achieved.23,48 Alginates provide several
advantages for biomedical applications: (1) they are non-toxic
and clinical-grade materials, thus unlikely to cause any immune
concerns;58 (2) they can be instantly cross-linked with Ca2+
ions without harming cells; (3) they are affordable and
available;58 (4) the resultant hydrogel tubes can be easily
dissolved with 0.5 mM EDTA solution to release the cell
products; (5) they allow quick nutrient diffusion through the
alginate hydrogel shell; (6) they are mechanically and
chemically stable, allowing long-term and large-scale cell
cultures; and (7) they are transparent, allowing for optical
monitoring.58 In particular, frequent passaging is the drawback
for large-scale cell production since it is time-, labor-, and
Figure 5. Whole transcriptome analysis of 3D-alginate-ECs, 3D-PEG-ECs, and 2D-ECs derived from H9s. (A,B) Global heat map of expressed
genes and PCA of all ECs. (C) Heat map representation of the Spearman rank correlation coefficient between methods. Correlation color key goes
from white (0, no correlation) to blue (1, perfect correlation). (D) Scatterplot in the log scale of gene expression for all ECs. Three biological
replicates are used for each sample.
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Figure 6. Differential gene expression analysis among all ECs derived from H9s. (A,B) Top 10 upregulated GO terms in the 3D-PEG-EC and 3D-
alginate-EC groups compared with 2D-ECs, respectively. (C,D) Venn diagram showing the upregulated and downregulated gene counts in 2D-EC,
3D-PEG-EC, and 3D-alginate-EC groups. (E−I) log 2 (expression level in 3D-PEG-ECs or 3D-alginate-ECs/expression level in 2D-ECs) of
extracellular matrix genes. (J−M) log 2 (expression level in 3D-PEG-ECs or 3D-Alginate-ECs/expression level in 2D-ECs) of genes related to EC
secretome (J), glycolysis (K), angiogenesis (L), and proliferation (M).
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https://dx.doi.org/10.1021/acsomega.0c06187
ACS Omega 2021, 6, 6942−6952
6948
reagent-consuming and poses the risk of contamination and
culture failure, resulting in the loss of large numbers of cells
and causing difficulties during automation. In addition,
according to our data, we demonstrated that the 3D
microenvironment could enhance ECM genes, key genes,
and cellular factors related to ECs by RNA sequencing (Figure
6) and qRT-PCR analysis (Figure 5G,H), which benefits the
production of functional ECs (Figure 5A−F). Thus, the 3D
environment offers many features that benefit the hPSC
biology and culture, including supporting cell growth and
differentiation, prevention of large cell aggregate formation,
isolation of cells from shear forces, and sufficient porosity for
nutrient diffusion.
■ CONCLUSIONS
In summary, we made a detailed comparative study for hPSC-
EC generation from the 2D, 3D-PEG hydrogel, and 3D-
alginate hydrogel culture systems and demonstrated that
hPSC-ECs generated from both hydrogel systems displayed a
functional phenotype, while 2D-ECs showed a proliferative
phenotype, according to their gene expressions related to ECs
and functional properties. Finally, taking all aspects into
consideration, including the cell yield and quality, the number
of cell passages, cost-effectiveness, scalable production,
physiologically relevant microenvironment, time-/labor-/
space-/reagent-consumption, gene expression, and functional
properties, we believe that the 3D-alginate hydrogel culture
system will become a versatile culture system and will make
hPSCs or their derivatives broadly available for various
applications.
■ EXPERIMENTAL SECTION
Routine Cell Culture. H9 hESCs (#WA09, WiCell) were
purchased from the WiCell Research Institute. hPSCs were
cultured in well-plate pre-coated with Matrigel (#354277, BD
Biosciences) in the Essential 8 medium (E8, #A1517001,
Invitrogen). Cells were passaged every 4 days with 0.5 mM
EDTA (#AM9260G, Invitrogen). The medium was changed
daily. Cells were routinely checked for the expression of
pluripotency markers, OCT4 and NANOG, their capability to
form teratomas in immunodeficient mice, their karyotypes, and
bacterial or mycoplasma contamination. HUVECs
(#00191027, Lonza) were obtained from Lonza.
Culturing hPSCs in 3D PNIPAAm-PEG Hydrogels. The
method for the hPSC culture in 3D PNIPAAm-PEG hydrogels
has been described in our previous publications.23,51 Briefly,
hPSCs were dissociated into single cells with Accutase
(#A1110501, Life Technologies), mixed with 10% PNI-
PAAm-PEG solution dissolved in E8 medium on ice, cast on
the tissue culture plate, and then incubated at 37 °C for 10 min
to form hydrogels, before warm E8 medium containing a 10
μM ROCK inhibitor (RI, Y-27632, #Y5301, LC Laboratories)
was added. To passage cells, the medium was removed after
culturing cells for 5 days, and pre-cold PBS was added to
dissolve the hydrogel. Cell spheroids were collected by
spinning at 100 g for 3 min. Cells were incubated in Accutase
at 37 °C for 10 min and dissociated into single cells.
Extruding Alginate Hydrogel Tubes and Culturing
hPSCs. Alginate hydrogel tubes are processed as described in
our previous publication.48 Briefly, a custom-made micro-
extruder was used to process the alginate tubes. A hyaluronic
acid (Lifecore Biomedical, #HA700K-5) solution containing
single cells and an alginate (Wako Chemicals, 80-120 cp, #194-
13321) solution were pumped into the central and side
channels of the home-made micro-extruder, respectively, and
extruded into a CaCl2 buffer (100 mM) to make alginate
hydrogel tubes. Subsequently, CaCl2 buffer was replaced by the
cell culture medium. The method for the hPSC culture in
alginate hydrogel tubes has been described in our previous
publication.48
Making hPSC-ECs in 2D Culture, 3D-PEG Hydrogel, or
3D-Alginate Hydrogel Systems. For EC differentiation in
2D culture, hPSCs were dissociated into single cells with
Accutase and plated on Matrigel-coated plates at a density of
40,000 cells/cm2 in E8 medium with 10 μM RI. After 24 h, the
medium was replaced with a differentiation medium, consisting
of a 1:1 mixture of DMEM/F12 (#SH30004.04, HyClone)
with Glutamax-I (#35050061, Life Technologies) and Neuro-
basal Medium (#21103049, Life Technologies) supplemented
with N2 (#17502048, Life Technologies) and B27 minus
vitamin A (#12587010, Life Technologies), with 8 μM
CHIR99021 (#C6556, LC Laboratories) and 25 ng/mL
BMP4 (#314BP010, R&D Systems). After 3 days, the
differentiation medium was replaced by an EC induction
medium consisting of StemPro-34 SFM medium (#10639011,
Life Technologies) supplemented with 200 ng/mL VEGFA
(#100-20, PeproTech) and 2 μM Forskolin (#F3917, Sigma).
On day 6, ECs were replated on human fibronectin (#F1141,
Sigma)-coated dishes for EC expansion with a medium
consisting of EGM-2 medium (#CC3162, Lonza) supple-
mented with 50 ng/mL VEGFA.
For ECs differentiation in 3D-PEG or 3D-alginate system,
single hPSCs were encapsulated in both hydrogels (1.0 × 106
cells/mL hydrogel) and cultured in E8 medium for 5 days.
Then, the E8 medium was removed and replaced with an EC
differentiation medium. After 3 days, the differentiation
medium was replaced by an EC induction medium. The
induction medium was changed after 1 day. On day 10, cell
masses were collected for the following analysis.
Immunostaining. For 2D immunostaining, the cells were
fixed with 4% paraformaldehyde (PFA) at room temperature
for 20 min, permeabilized with 0.25% Triton X-100 for 30 min,
and blocked with 5% donkey serum for 1 h before being
incubated with primary antibodies (Table S1) at 4 °C
overnight. After extensive washing, secondary antibodies
(Table S1) and 10 μM 4′,6-diamidino-2-phenylindole
(DAPI) in 2% bovine serum albumin (BSA) were added and
incubated at room temperature for 4 h. Cells were washed with
PBS three times before imaging with an A1 confocal
microscope. For 3D immunostaining, cell masses were fixed
for 30 min and then incubated with PBS +0.25% Triton X-100
+5% (vol/vol) goat serum + primary antibodies at 4 °C for 48
h. After extensive washing, secondary antibodies in 2% BSA
were added and incubated at 4 °C for 24 h. Cells were washed
with PBS three times before the imaging with a confocal
microscope.
Flow Cytometry. The harvested cells were dissociated into
single cells with Accutase and then fixed with 4% PFA at room
temperature for 20 min. Single cells were stained with primary
antibodies (Table S1) at 4 °C overnight. After washing the
cells three times with 1% BSA in PBS, secondary antibodies
were added and incubated at room temperature for 2 h. Cells
were washed with 1% BSA in PBS and analyzed using a Cytek
DxP10 flow cytometer. Single-color and isotype controls
served as compensation and negative gating, respectively.
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Quantitative Real-Time PCR. Total RNA for qPCR and
RNA sequencing were extracted from 2D-ECs on day 6 and
from PEG-ECs and alginate-ECs on day 10 of the differ-
entiation using Trizol (#15596018, Invitrogen), according to
the manufacturer’s instructions. Reverse transcription was
done with a Maxima First Strand cDNA Synthesis Kit
(#K1642, Life Technologies). Quantitative real-time PCR
was carried out in an Eppendorf MasterCycler RealPlex4
(ThermoFisher Scientific) using the Power SYBR Green PCR
Master Mix (#4367659, ThermoFisher), according to the
manufacturer’s instructions. The data were normalized to the
endogenous GAPDH. Primer sequences are listed in Table S2.
Tube Formation. A volume of 200 μL of Matrigel was
aliquoted into each well of a 12-well plate and incubated for 30
min at 37 °C to allow the gel to solidify. Then, 80,000 hPSC-
ECs were seeded onto the matrix and cultured for 24 h at 37
°C until image acquisition. Cells were fixed with 2% PFA for
10 min and analyzed using a Zeiss fluorescence microscope.
Uptake of Dil-Ac-LDL. Cells were incubated with 2.5 g/
mL DiI-Ac-LDL-Alexa597 (#L3484, Molecular Probes/Life
Technologies) in StemPro-34 medium for 4 h at 37 °C.
Thereafter, cells were washed three times with PBS and fixed
with 4% PFA for 10 min. DNA was counterstained with DAPI.
The cellular uptake of DiI-Ac-LDL-Alexa 597 was visualized
with a fluorescence microscope (Zeiss).
Trans-endothelial Electrical Resistance. hPSC-ECs
were seeded at a density of 1.0 × 106 cells/mL on 24-well
cell culture inserts (0.4 μM pore size, cat # 3470, Corning)
coated with fibronectin. Cells were grown for 72 h in EGM-2
medium. The medium was then changed to a starvation
medium (basal EBM medium + 0.5% fetal bovine serum) with
or without vascular permeability factors (100 ng/mL TNF-α
(cat # 300-01A, Peprotech), IL-1β (cat # 200-01B, Peprotech),
and 100 ng/mL VEGF-A) for 30 h. TEER was recorded using
the Digital AC/DC clamp meter (cat #MS2101, MASTECH).
This experiment was performed in triplicate for each condition
and repeated three times. Results are depicted as the steady-
state TEER values with the blank filter subtracted.
Matrigel Plug Assay. Animal procedures were performed
in accordance with an IACUC-approved protocol reviewed by
the University of Nebraska−Lincoln Animal Care and Use
Committee. Female 6- to 8-week-old SCID mice (Charles
River Laboratory) were used. Differentiated ECs were added
to the Matrigel mixture to a final concentration of 10 million
cells/mL. The Matrigel mixture (300 μL) was then
immediately engrafted subcutaneously into the dorsal flank
of the mouse. Two implants were engrafted per animal.
Implants were recovered after 14 days, and then, the implants
were excised. They were fixed in 4% PFA. H&E staining and
immunostaining were performed to analyze the tube formation
potential in vivo.
RNA Sequencing and Data Analysis. Total RNA of day
6 ECs cultured in 2D culture (n = 3) and day 10 ECs cultured
in PEG (n = 3) and alginate hydrogel systems (n = 3) were
prepared with an RNeasy mini kit (cat # 74104 QIAGEN)
according to the manufacturer’s instruction. Libraries were
prepared with a TruSeq Stranded mRNA Library Prep Kit and
sequenced with Illumina NextSeq 500. 20 million 75 bp
paired-end reads were generated for each sample. Methods for
the data processing, heatmap generating, PCA analysis, GO
terms, and differential gene expression analysis have been
described in previous publications.48,51 A sample size of three
and three biological replicates were used for each group.
Statistical Analysis. The data are presented as the mean ±
standard deviation (SD) from three independent experiments.
We used an unpaired t-test to compare two groups and one-
way ANOVA to compare more than two groups. A sample size
of three was selected so that at a significance level of 0.05,
there was at least 95% chance of detecting two SD’s difference
in the outcome between the groups. All data were processed
using GraphPad Prism 8 (GraphPad Software, Inc., La Jolla,
CA).
Accession Numbers. The accession numbers for the data
reported in this article are GEO: GSE99776 and GSE109683.
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